• Home (current)
  • La Società
    Chi siamo Soci collettivi Collaborazioni tecniche Bilancio societario
  • Sezioni Regionali
  • Convegni e Formazione
    Eventi SINU Altri eventi Eventi patrocinati
  • Newsletters
  • Cerca
  • Come iscriversi
  • Area Soci:
  • Registrati
  • Login
  • English version
  • Passa al contenuto principale

SINU

Società Italiana di Nutrizione Umana

EFSA – Valutati i rischi connessi alla presenza di ocratossina A negli alimenti

The European Commission asked EFSA to update their 2006 opinion on ochratoxin A (OTA) in food. OTA is produced by fungi of the genus Aspergillus and Penicillium and found as a contaminant in various foods. OTA causes kidney toxicity in different animal species and kidney tumours in rodents. OTA is genotoxic both in vitro and in vivo; however, the mechanisms of genotoxicity are unclear. Direct and indirect genotoxic and non‐genotoxic modes of action might each contribute to tumour formation. Since recent studies have raised uncertainty regarding the mode of action for kidney carcinogenicity, it is inappropriate to establish a health‐based guidance value (HBGV) and a margin of exposure (MOE) approach was applied. For the characterisation of non‐neoplastic effects, a BMDL10 of 4.73 μg/kg body weight (bw) per day was calculated from kidney lesions observed in pigs. For characterisation of neoplastic effects, a BMDL10 of 14.5 μg/kg bw per day was calculated from kidney tumours seen in rats. The estimation of chronic dietary exposure resulted in mean and 95th percentile levels ranging from 0.6 to 17.8 and from 2.4 to 51.7 ng/kg bw per day, respectively. Median OTA exposures in breastfed infants ranged from 1.7 to 2.6 ng/kg bw per day, 95th percentile exposures from 5.6 to 8.5 ng/kg bw per day in average/high breast milk consuming infants, respectively. Comparison of exposures with the BMDL10 based on the non‐neoplastic endpoint resulted in MOEs of more than 200 in most consumer groups, indicating a low health concern with the exception of MOEs for high consumers in the younger age groups, indicating a possible health concern. When compared with the BMDL10 based on the neoplastic endpoint, MOEs were lower than 10,000 for almost all exposure scenarios, including breastfed infants. This would indicate a possible health concern if genotoxicity is direct. Uncertainty in this assessment is high and risk may be overestimated.

Consulta il documento


HOME

LARN IV revisione
NMCD
Meno sale più salute
Come iscriversi
Questionari
Il Punto su…
Congresso SINU 2019
Documenti SINU

LA SOCIETA'

Chi siamo
Soci collettivi
Collaborazioni tecniche
Biancio societario

FORMAZIONE

Eventi SINU
Altri eventi
Eventi patrocinati

NEWS

In evidenza
News recenti

CONTATTI

Sezioni regionali
Gruppi di lavoro
Privacy policy

SEGRETERIA SINU

c/o BioMedia srl
via Libero Temolo 4
20126 Milano
02 45498282
02 45498199
info@sinu.it

Copyright © 2019 SINU - Tutti i diritti riservati.


Un progetto realizzato da: BioMedia srl.

Recupera password

Presto Disponibile